AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(3), 2001, pp. 197-203
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owusu-Agyei, S
Right arrow Articles by Hoffman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owusu-Agyei, S
Right arrow Articles by Hoffman, S.
Related Collections
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 3, 197-203
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana

S Owusu-Agyei, KA Koram, JK Baird, GC Utz, FN Binka, FK Nkrumah, DJ Fryauff, and SL Hoffman

Adult residents of holoendemic malaria regions in Africa have a naturally acquired immunity (NAI) to malaria that renders them more resistant to new infections, limits parasitemia, and reduces the frequency and severity of illness. Given such attributes, it is not clear how one might evaluate drug or vaccine efficacy in adults without serious confounding. To determine symptomatic and asymptomatic malaria attack rates in adults of northern Ghana, 197 men and women underwent curative therapy for any pre-existing malaria infections at the start of the high transmission (wet) season. They were monitored for first parasitemia and first clinical episode of infection by Plasmodium falciparum over a 20-week period (May-October 1996). The cumulative incidence of primary infection by P. falciparum was 0.98 and incidence density of infection was calculated to be 7.0 cases/person-year. Symptoms were reported by 19.5% of the individuals at the time of first recurrent parasitemia. Incidence of infection, parasite density, and the frequency of symptoms were comparable in males and females. The results suggest that NAI did not provide these adults with significant defense against rapid re-infection and suggest that this population-infection design could serve to demonstrate the efficacy of a drug or vaccine in preventing parasitemia.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. Belnoue, T. Voza, F. T. M. Costa, A. C. Gruner, M. Mauduit, D. S. Rosa, N. Depinay, M. Kayibanda, A. M. Vigario, D. Mazier, et al.
Vaccination with Live Plasmodium yoelii Blood Stage Parasites under Chloroquine Cover Induces Cross-Stage Immunity against Malaria Liver Stage
J. Immunol., December 15, 2008; 181(12): 8552 - 8558.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. D. Osafo-Addo, K. A. Koram, A. R. Oduro, M. Wilson, A. Hodgson, and W. O. Rogers
HLA-DRB1*04 Allele Is Associated with Severe Malaria in Northern Ghana
Am J Trop Med Hyg, February 1, 2008; 78(2): 251 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
T. SMITH, N. MAIRE, K. DIETZ, G. F. KILLEEN, P. VOUNATSOU, L. MOLINEAUX, and M. TANNER
RELATIONSHIP BETWEEN THE ENTOMOLOGIC INOCULATION RATE AND THE FORCE OF INFECTION FOR PLASMODIUM FALCIPARUM MALARIA.
Am J Trop Med Hyg, August 1, 2006; 75(2_suppl): 11 - 18.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
K. N. Suh, K. C. Kain, and J. S. Keystone
Malaria
Can. Med. Assoc. J., May 25, 2004; 170(11): 1693 - 1702.
[Abstract] [Full Text]

Home page
 J. Exp. Biol.Home page
T. C. Luke and S. L. Hoffman
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine
J. Exp. Biol., November 1, 2003; 206(21): 3803 - 3808.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.